Indigenous access to clinical services along the lung cancer treatment pathway: a review of current evidence
Cancer Causes & Control · 2024
DOI: 10.1007/s10552-024-01904-1 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Causes & Control, 2024. Verfasst von Virginia Signal und 8 weiteren Autor:innen. Beteiligte Einrichtung: University of Otago Wellington, Newtown, PO Box 7343, Wellington, 6242, New Zealand. Hauptthemen laut MEDLINE: Health Services Accessibility, Lung Neoplasms. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health Research Council of New Zealand, University of Otago.
Abstract (Originalsprache)
Background
Lung cancer is a deadly cancer. Early diagnosis and access to timely treatment are essential to maximizing the likelihood of survival. Indigenous peoples experience enduring disparities in lung cancer survival, and disparities in access to and through lung cancer services is one of the important drivers of these disparities. In this manuscript, we aimed to examine the current evidence on disparities in Indigenous access to services along the lung cancer treatment pathway.
Methods
A narrative literature review was conducted for all manuscripts and reports published up until July 20, 2022, using Medline, Scopus, Embase, and Web of Science. Following the identification of eligible literature, full-text versions were scanned for relevance for inclusion in this review, and relevant information was extracted. After scanning 1,459 documents for inclusion, our final review included 36 manuscripts and reports that included information on lung cancer service access for Indigenous peoples relative to non-Indigenous peoples. These documents included data from Aotearoa New Zealand, Australia, Canada, and the USA (including Hawai’i).
Results
Our review found evidence of disparities in access to, and the journey through, lung cancer care for Indigenous peoples. Disparities were most obvious in access to early detection and surgery, with inconsistent evidence regarding other components of the pathway.
Conclusion
These observations are made amid relatively scant data in a global sense, highlighting the need for improved data collection and monitoring of cancer care and outcomes for Indigenous peoples worldwide. Access to early detection and guideline-concordant treatment are essential to addressing enduring disparities in cancer survival experienced by Indigenous peoples globally.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Otago Wellington, Newtown, PO Box 7343, Wellington, 6242, New Zealand.
- Te Whatu Ora - Southern, Dunedin, New Zealand.
- Te Whatu Ora - Counties Manukau, Auckland, New Zealand.
- Department of Medicine, University of Otago, Dunedin, New Zealand.
- Te Whatu Ora - Waitematā, Auckland, New Zealand.
- University of Waikato, Hamilton, New Zealand.
Förderung
- Health Research Council of New Zealand
- University of Otago
Zitieren
APA
Signal, V., Smith, M., Costello, S., Davies, A., Dawkins, P., Jackson, C. G. C. A., Koea, J., Whitehead, J., & Gurney, J. (2024). Indigenous access to clinical services along the lung cancer treatment pathway: a review of current evidence. Cancer Causes & Control. https://doi.org/10.1007/s10552-024-01904-1
Vancouver
Signal V, Smith M, Costello S, Davies A, Dawkins P, Jackson CGCA, et al. Indigenous access to clinical services along the lung cancer treatment pathway: a review of current evidence. Cancer Causes & Control. 2024. doi:10.1007/s10552-024-01904-1
BibTeX
@article{Signal2024,
author = {Signal, Virginia and Smith, Moira and Costello, Shaun and Davies, Anna and Dawkins, Paul and Jackson, Christopher G C A and Koea, Jonathan and Whitehead, Jesse and Gurney, Jason},
title = {Indigenous access to clinical services along the lung cancer treatment pathway: a review of current evidence},
journal = {Cancer Causes & Control},
year = {2024},
doi = {10.1007/s10552-024-01904-1}
}
EUVIMED